Sanofi (Sanofi) Price-to-Tangible-Book : (As of Apr. 25, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Sanofi Price-to-Tangible-Book?

As of today (2024-04-25), Sanofi's share price is $49.36. Sanofi's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was $-0.52. Hence, Sanofi's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Sanofi's Price-to-Tangible-Book or its related term are showing as below:

SNY' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 15.24 Med: 26.9 Max: 382.65
Current: 379.69

During the past 13 years, Sanofi's highest Price to Tangible Book Ratio was 382.65. The lowest was 15.24. And the median was 26.90.

SNY's Price-to-Tangible-Book is ranked worse than
99.66% of 873 companies
in the Drug Manufacturers industry
Industry Median: 2.35 vs SNY: 379.69

A closely related ratio is called PB Ratio. As of today, Sanofi's share price is $49.36. Sanofi's Book Value per Sharefor the quarter that ended in Jun. 2023 was $31.44. Hence, Sanofi's P/B Ratio of today is 1.57.

Sanofi Price-to-Tangible-Book Historical Data

The historical data trend for Sanofi's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Price-to-Tangible-Book Chart

Sanofi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

35.45

360.36

Sanofi Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	35.45	-	360.36

Competitive Comparison of Sanofi's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Sanofi's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sanofi's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Sanofi's Price-to-Tangible-Book falls into.

Sanofi Price-to-Tangible-Book Calculation

Sanofi's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	49.36	/	-0.521
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Sanofi Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Sanofi's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi (Sanofi) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:Mexico SANF:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SANO:Austria

Address

46, avenue de la Grande Armée, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.